Finance / IDEV (Indevus Pharmaceuticals Inc.)

DOW JONES NEWSWIRES Endo Pharmaceuticals Holdings Inc. (ENDP) signed an agreement with ProStrakan Group PLC (PSK.LN) for the exclusive right to sell the U.K. drug company's Fortesta testosterone-replacement therapy gel in the U.S. The deal is the latest move by the U.S. specialty drug company to expand into new markets. Endo has been expanding beyond pain management into urology, ...